Evidence map›Paper›PMID 41844777›Full record

ArticleScientific reports2026

Deep learning based 3D brain metastasis synthesis with configurable parameters for 3D data augmentation.

Gengyan Zhao, Eli Gibson, Youngjin Yoo, Thomas J Re, Jyotipriya Das, Hesheng Wang, Michelle M Kim, Colette Shen, Yueh Lee, Douglas Kondziolka and 7 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Gengyan ZhaoDigital Technology and Innovation, Siemens Healthineers, 755 College Road East, Princeton, 08540-6632, NJ, USA. gengyan.zhao@gmail.com.
Eli GibsonDigital Technology and Innovation, Siemens Healthineers, 755 College Road East, Princeton, 08540-6632, NJ, USA.
Youngjin YooDigital Technology and Innovation, Siemens Healthineers, 755 College Road East, Princeton, 08540-6632, NJ, USA.
Thomas J ReDigital Technology and Innovation, Siemens Healthineers, 755 College Road East, Princeton, 08540-6632, NJ, USA.
Jyotipriya DasDigital Technology and Innovation, Siemens Healthineers, 755 College Road East, Princeton, 08540-6632, NJ, USA.
Hesheng WangDepartment of Radiation Oncology, New York University, New York, NY, USA.
Michelle M KimDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
Colette ShenDepartment of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA.
Yueh LeeDepartment of Radiology, University of North Carolina, Chapel Hill, NC, USA.
Douglas KondziolkaCenter for Advanced Radiosurgery, New York University, New York, NY, USA.
Mohannad IbrahimDepartment of Radiology, University of Michigan, Ann Arbor, MI, USA.
Jun LianDepartment of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA.
Rajan JainDepartment of Radiology, New York University, New York, NY, USA.
Hemant ParmarDepartment of Radiology, University of Michigan, Ann Arbor, MI, USA.
Dorin ComaniciuDigital Technology and Innovation, Siemens Healthineers, 755 College Road East, Princeton, 08540-6632, NJ, USA.
James M BalterDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
Yue CaoDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.

Funding

NIH HHS R01 CA262182-01
6 · The paper itself

Abstract

To develop and evaluate deep learning methods for synthesizing 3D brain metastases (BM) on magnetic resonance (MR) images to improve downstream BM detection and segmentation performances for robust clinical detection and streamlined treatment-planning workflows, T1-weighted MR images of 1832 patients with 10,276 BM were divided into training (80%), validation (10%), and test (10%) datasets for training the BM synthesis models and downstream models for BM detection and segmentation. A 3D-2D generative adversarial network with controllable configurations for 3D BM synthesis was proposed. The network consists of two 3D generators to create 3D lesion intermediate representations controlling the lesion’s characteristics and 3D continuity, and a 2D generator with a 2D perceptual loss to generate realistic lesion images slice by slice. Training with synthetic data (SD) and conventional augmentation (CA) on the downstream tasks were compared using two-sided pairwise Wilcoxon signed rank test. SD showed improvement on the BM detection and segmentation downstream tasks with limited training data. Especially, when 10% of the original training data was available, adding 176 SD improved BM segmentation Dice by 2.9% relative to CA alone (0.665 vs. 0.646, p < 0.0001). With 8000 SD, segmentation boundary accuracy further improved, reducing HD95 by 10.5% and ASSD by 23.5% compared with CA alone.

Indexed as

Brain NeoplasmsDeep LearningImaging, Three-DimensionalGenerative Adversarial NetworksGenerative Artificial IntelligenceHumansMagnetic Resonance ImagingBrain metastasisGenerative adversarial networkImage synthesisLesion detectionMRISegmentation

Identifiers

PMID41844777
PMCPMC13187180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.